Low molecular weight hyaluronan induces lymphangiogenesis through LYVE-1-mediated signaling pathways

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Wu, Man ^a   Du, Yan ^a   Liu, Yiwen ^a   He, Yiqing ^a   Yang, Cuixia ^a   Wang, Wenjuan ^a   Gao, Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LOW MOLECULAR WEIGHT HYALURONAN; LYMPHALIC VESSEL ENDOTHELIAL HYALURONAN RECEPTOR 1; MEMBRANE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C ALPHA; UNCLASSIFIED DRUG; GLYCOPROTEIN; IMMUNOLOGICAL ADJUVANT; PROTEIN KINASE; XLKD1 PROTEIN, MOUSE;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME PHOSPHORYLATION; FILOPODIUM; IN VITRO STUDY; LAMELLIPODIUM; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; MOUSE; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STRESS FIBER; TUBE FORMATION; ANIMAL; CELL MOTION; CYTOLOGY; DRUG EFFECTS; METABOLISM; MOLECULAR WEIGHT; TRANSFORMED CELL LINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; GLYCOPROTEINS; HYALURONIC ACID; LYMPHANGIOGENESIS; MAP KINASE SIGNALING SYSTEM; MICE; MOLECULAR WEIGHT; PROTEIN KINASES;

EID: 84899817020     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092857     Document Type: Article

References (49)

1. Saharinen P, Tammela T, Karkkainen M J, Alitalo K (2004) Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 25 (7): 387-395. (Pubitemid 38780956)
2. Toole BP (2002) Hyaluronan promotes the malignant phenotype. Glycobiology 12 (3): 37R-42R.
3. Hayen W, Goebeler M, Kumar S, Rieben R, Nehls V (1999) Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture. J Cell Sci 112 (13): 2241-2251. (Pubitemid 29355439)
4. Itano N, Atsumi F, Sawai T, Yamada Y, Miyaishi O, et al. (2002) Abnormal accumulation of hyaluronan matrix diminishes contact inhibition of cell growth and promotes cell migration. Proc Natl Acad Sci U S A 99 (6): 3609-3614. (Pubitemid 34252154)
5. Zhang Y, Thant AA, Machida K, Ichigotani Y, Naito Y, et al. (2002) Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90. Cancer Res 62 (14): 3962-3965. (Pubitemid 34791060)
6. Liu N, Gao F, Han Z, Xu X, Underhill CB, et al. (2001) Hyaluronan synthase 3 overexpression promotes the growth of TSU prostate cancer cells. Cancer Res 61 (13): 5207-5214. (Pubitemid 32681555)
7. Simpson MA, Wilson CM, McCarthy JB (2002) Inhibition of prostate tumor cell hyaluronan synthesis impairs subcutaneous growth and vascularization in immunocompromised mice. The Am J Pathol 161 (3): 849-857. (Pubitemid 34988372)
8. Guo LX, Zou K, Ju JH, Xie H (2005) Hyaluronan promotes tumor lymphangiogenesis and intralymphantic tumor growth in xenografts. Acta Biochim Biophys Sin 37 (9): 601-606. (Pubitemid 43002364)
9. Sathish KG (2008) Role of NOTCH and hyaluronan in modulating the expression of lymphatic vessel endothelial hyaluronan receptor1 (LYVE-1). MS Thesis, University of Southern California, Los Angeles.
10. Jiang D, Liang J, Noble PW (2007) Hyaluronan in tissue injury and repair. Annu Rev Cell Dev Biol 23: 435-461.
11. Tammi MI, Day AJ, Turley EA (2002) Hyaluronan and homeostasis: a balancing act. J Biol Chem 277 (7): 4581-4584. (Pubitemid 34968482)
12. Toole BP, Wight TN, Tammi MI (2002) Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem 277 (7): 4593-4596. (Pubitemid 34968485)
13. Evanko SP, Tammi MI, Tammi RH, Wight TN (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59 (13): 1351-1365. (Pubitemid 350088257)
14. Turley EA, Noble PW, Bourguignon LY (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277 (7): 4589-4592. (Pubitemid 34968484)
15. Stern R, Asari AA, Sugahara KN (2006) Hyaluronan fragments: an information-rich system. Eur J Cell Biol 85 (8): 699-715. (Pubitemid 44070579)
16. Sherman L, Sleeman J, Herrlich P, Ponta H (1994) Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6 (5): 726-733. (Pubitemid 24295307)
17. Aruffo A, Stamenkovic I, Melnick M, Underhill CB, Seed B (1990) CD44 is the principal cell surface receptor for hyaluronate. Cell 61 (7): 1303-1313.
18. Turley EA, Hossain MZ, Sorokan TJLM, Jordan LM, Nagy JI (1994) Astrocyte and microglial motility in vitro is functionally dependent on the hyaluronan receptor RHAMM. Glia 12 (1): 68-80. (Pubitemid 2145968)
19. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2): 192-198. (Pubitemid 32148486)
20. Mattila MMT, Ruohola JK, Karpanen T, Jackson DG, Alitalo K, et al. (2002) VEGF-C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF-7 tumors. Int J Cancer 98 (6): 946-951. (Pubitemid 34286696)
21. O'Connell KA, Edidin M (1990) A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional characteristics of normal endothelial cells. J Immunol 144 (2): 521-525. (Pubitemid 20036078)
22. Kuzmenko ES, Djafarzadeh S, Çakar ZP, Fiedler K (2004) LDL transcytosis by protein membrane diffusion. Int J Biochem Cell Biol 36 (3): 519-534. (Pubitemid 37542449)
23. Chang VWH, Ho YS (2001) Structural characterization of the mouse Foxf1a gene. Gene 267 (2): 201-211.
24. Ledgerwood LG, Lal G, Zhang N, Garin A, Esses SJ, et al. (2007) The sphingosine 1-phosphate receptor 1 causes tissue retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent lymphatics. Nat Immunol 9 (1): 42-53. (Pubitemid 350286203)
25. Hou WH, Liua IH, Huang SS, Huang JS (2012) CRSBP-1/LYVE-1 ligands stimulate contraction of the CRSBP-1-associated ER network in lymphatic endothelial cells. FEBS lett 586 (10): 1480-1487.
26. Deed R, Rooney P, Kumar P, Norton JD, Smith J, et al. (1997) Early-response gene signalling is induced by angiogenic oligosaccharides of hyaluronan in endothelial cells. Inhibition by non-angiogenic, high-molecular-weight hyaluronan. Int J cancer 71 (2): 251-256. (Pubitemid 27252999)
27. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (5240): 1326-1331.
28. Slevin M, Krupinski J, Kumar S, Gaffney J (1998) Angiogenic oligosaccharides of hyaluronan induce protein tyrosine kinase activity in endothelial cells and activate a cytoplasmic signal transduction pathway resulting in proliferation. Laboratory inves 78 (8): 987-1003.
29. Mumprecht V, Detmar M (2009) Lymphangiogenesis and cancer metastasis. J cell Mol Med 13 (8a): 1405-1416.
30. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, et al. (2001) Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J, 20 (4): 672-682. (Pubitemid 32167632)
31. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, et al. (2001) Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 7 (2): 192-198. (Pubitemid 32148486)
32. Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, et al. (2001) Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. J Biol Chem 276 (15): 11922-11932.
33. Slevin M, West D, Kumar P, Rooney P, Kumar S (2004) Hyaluronan, angiogenesis and malignant disease. Int J Cancer 109 (5): 793-794.
34. Kumar S, West DC, Ponting JM, Gattamaneni HR (1989) Sera of children with renal tumours contain low-molecular-mass hyaluronic acid. Int J Cancer 44 (3): 445-448. (Pubitemid 19229301)
35. Noble PW (2002) Hyaluronan and its catabolic products in tissue injury and repair. Matrix Biol 21 (1): 25-29.
36. West DC, Kumar S (1989) The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res 183 (1): 179-196. (Pubitemid 19166520)
37. Kouvidi K, Berdiaki A, Nikitovic D, Katonis P, Afratis N, et al. (2011) Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion. J Biol Chem 286 (44): 38509-38520.
38. Chalkiadaki G, Nikitovic D, Katonis P, Berdiaki A, Tsatsakis A, et al. (2011) Low molecular weight heparin inhibits melanoma cell adhesion and migration through a PKCa/JNK signaling pathway inducing actin cytoskeleton changes. Cancer lett 312 (2): 235-244.
39. Jackson DG, Prevo R, Clasper S, Banerji S (2001) LYVE-1, the lymphatic system and tumor lymphangiogenesis. Trends Immunol 22 (6):317-321. (Pubitemid 32675245)
40. Thorne RF, Legg JW, Isacke CM (2004) The role of the CD44 transmembrane and cytoplasmic domains in coordinating adhesive and signalling events. J Cell Sci 117 (3): 373-380. (Pubitemid 38181198)
41. Pollard JW (2008). Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol 84 (3): 623-630.
42. Banerji S, Ni J, Wang SX, Clasper S, Su J, et al. (1999) LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 144 (4): 789-801. (Pubitemid 29234556)
43. Hou WH, Liu IH, Tsai CC, Johnson FE, Huang SS, et al. (2011) CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin. J Cell Sci 124 (8): 1231-1244.
44. Du Y, Liu Y, Wang Y, He Y, Yang C, et al. (2011) LYVE-1 enhances the adhesion of HS-578T cells to COS-7 cells via hyaluronan. Clin Invest Med 34 (1): E45-E54.
45. Gao F, Cao M, Yang C, He Y, Liu Y (2006) Preparation and characterization of hyaluronan oligosaccharides for angiogenesis study. J Biomed Mater Res B Appl Biomater 78 (2): 385-392. (Pubitemid 44167744)
46. Slomiany MG, Dai L, Bomar PA, Knackstedt TJ, Kranc DA, et al. (2009) Abrogating drug resistance in malignant peripheral nerve sheath tumors by disrupting hyaluronan-CD44 interactions with small hyaluronan oligosaccharides. Cancer Res 69 (12): 4992-4998.
47. Slevin M, Kumar S, Gaffney J (2002) Angiogenic oligosaccharides of hyaluronan induce multiple signaling pathways affecting vascular endothelial cell mitogenic and wound healing responses. J Biol Chem 277 (43): 41046-41059. (Pubitemid 35215695)
48. Qian Y, Baisden JM, Westin EH, Guappone AC, Koay TC, et al. (1998) Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity. Oncogene 16 (17):2185-2195. (Pubitemid 28220648)
49. Nightingale TD, Frayne ME, Clasper S, Banerji S, Jackson DG (2009) A mechanism of sialylation functionally silences the hyaluronan receptor LYVE-1 in lymphatic endothelium. J Biol Chem 284 (6): 3935-3945.